Developing new drugs that activate the protective arm of the renin–angiotensin system as a potential treatment for respiratory failure in COVID-19 patients
Mathilde Latil, Serge Camelo, Stanislas Veillet, René Lafont, Pierre J. Dilda
Topics & Concepts
Renin–angiotensin systemAngiotensin-converting enzyme 2Coronavirus disease 2019 (COVID-19)ReceptorPneumoniaMedicinePharmacologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Angiotensin IIAngiotensin Receptor BlockersCoronavirusAngiotensin-converting enzymeInternal medicineInfectious disease (medical specialty)DiseaseBlood pressureCOVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchLong-Term Effects of COVID-19